| Male N = 13 (%) | Female N = 47 (%) | Total N = 60 (%) | Chi2 | p-value | Mantel–Haenszel test (Male = 1) | |
---|---|---|---|---|---|---|---|
OR | p-value | ||||||
Dementia (MMSE) | 7 (53.8) | 23 (48.9) | 30 (50) | 0.001 | 0.617 | 0.986 | 0.982 |
Depression (GDS) | 7 (53.8) | 19 (40.4) | 26 (43.3) | 0.74 | 0.29 | 0.582 | 0.39 |
Psychiatric treatment (previous) | 6 (46.2) | 17 (36.2) | 23 (38.3) | 0.429 | 0.365 | 0.661 | 0.514 |
Psychiatric treatment (current) | 4 (30.8) | 11 (23.4) | 15 (25) | 0.295 | 0.415 | 0.688 | 0.589 |
Mental disorder (patient’s history) | |||||||
 Depression | 2 (15.4) | 10 (21.3) | 12 (20) | 0.221 | 0.488 | 1.486 | 0.64 |
 Dementia | 1 (7.7) | 10 (21.3) | 11 (18.3) | 1.255 | 0.247 | 3.243 | 0.285 |
 Addiction | 2 (15.4) | 0 (0) | 2 (3.3) | 7.48 | 0.44 | – | – |
 Psychosis | 1 (7.7) | 3 (6.4) | 4 (6.7) | 0.028 | 0.634 | 0.818 | 0.867 |
Psychopharmacologic medication (current) | 7 (53.8) | 25 (53.2) | 32 (53.3) | 0.002 | 0.608 | 0.974 | 0.967 |
 Anxiolytic | 2 (15.4) | 11 (23.4) | 13 (21.7) | 0.386 | 0.422 | 1.618 | 0.538 |
 Hypnotic | 1 (7.7) | 3 (6.4) | 4 (6.7) | 0.028 | 0.634 | 0.818 | 0.867 |
 Antidepressant | 3 (23.1) | 8 (17) | 11 (18.3) | 0.249 | 0.443 | 0.684 | 0.619 |
 Antipsychotic | 3 (23.1) | 6 (12.8) | 9 (15) | 0.849 | 0.299 | 0.488 | 0.364 |